Tag: investors

akampion Meets…Dr. Roman Rittweger, Founder and CEO of Roman Rittweger Advisors in Healthcare and Organizer of the IIHC Conference


akampion: You are organizing a new conference called Innovations and Investments in Healthcare (IIHC). What is the idea behind this new event?

R.R.: I had been organizing an exclusive, invite-only German event for the past five years in Munich, but I felt it was time to open the format for new ideas and new people and also attract a broader, international audience. The past conferences have been very successful because we were not relying on the typical company presentations, but instead hosted interactive panels consisting of four experts and one senior partner of Roman Rittweger Advisors in Healthcare. No boring slides! The new event takes the concept even further and is, among others, inspired by the TED conferences.


akampion: So what exactly is the goal of the IIHC?

R.R.: Our goal is to present exciting international developments to healthcare players in Germany. We want to confront German opinion leaders with the latest business ideas from the US, Asia etc. As an example, take the mobile health businesses that arrived in the US and large parts of Asia already, but not here. We are also taking a look at how other countries organize and re-organize their healthcare systems, for example emerging countries. What is their cost-benefit assessment of proven and novel products?


akampion: Can you tell us more about the program?

R.R.: The program is a good mix of interactive panels, three-slide presentations in front of an expert jury, and so-called “speed-dating sessions”, which gives selected attendees the opportunity to tell others about his business. And the keynote is extremely important, too – this year, we got Brian David Johnson, Futurist and Director, Future Casting and Experience Research at Intel Labs, U.S. We even have panelists from Abu Dhabi and Kazakhstan, where the healthcare systems are currently being completely re-invented.  Moreover, a trauma surgeon will introduce telemedicine approaches to improve the treatment of traffic accident victims, we will talk about the “quantified self”-movement and how health and gene data can help to improve quality of life and the healthcare system. We will also discuss what drives investments in healthcare, what regulators require these days from innovations and what pharma and medtech companies can learn from a venture capital fund.


akampion: Who is your target audience?

R.R.: We are primarily targeting German decision makers, but will increase the number of international attendees over time, e.g. from Scandinavia or Eastern Europe. It is important to us that we attract representatives from both start-ups and emerging markets, as well as established companies and countries. Regulators and payors are key target groups, too.


akampion: Sounds very exciting! Last but not least – why did you choose a venue in Berlin?

R.R.: We are fully aware that the informal part of a conference is extremely important, especially for networking and attracting a broader international crowd. Therefore, we have decided to host the conference in Berlin. We will also have evening receptions and offer our attendees the opportunity to explore Berlin´s fascinating nightlife.


More information about the IIHC can be found at www.iihc.eu

akampion Meets…

We are currently establishing a new section called akampion Meets… Here you will find interviews with executives, investors, journalists, consultants and other professionals who share their personal opinions, experiences and insights. Check back soon!

Food for Thought: Why Do Private Companies Need IR, Too?

With an increasing number of emerging private equity trading platforms worldwide, it has become obvious that professional investor relations is not just for publicly listed companies. Even though transparency requirements for private companies are still much lower than those for listed companies, there are challenges ahead. While previously targeting a relatively small group of specialized private equity investors, private companies are now facing a very heterogenous audience of private (and, often times, anonymous) investors with very little knowledge about specific industy sectors and business models. Germany´s latest private equity market place, fianc, was launched earlier this week and follows the route of established players in the U.S. like SecondMarket and SharesPost.

It remains to be seen whether the new private equity trading platforms will eventually trigger more stricter regulatory and communication requirements – which, in turn, could mean that being a private company loses its charm. On the other hand, it is an excellent opportunity for private companies to broaden their shareholder base and attract additional capital. According to IR Magazine´s newsletter Inside Investor Relations, some analysts have started to focus entirely on this new market segment. That said, it is obvious that private companies need to re-think and adapt their communication strategies and resources if they want to position themselves successfully on the new trading platforms. Feel free to contact us if you need advice on trading your company´s shares on the private market.